Alvotech - Warrant — Cash Flow (NASDAQ:ALVOW) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics Dividends

Quarterly Annual

Cash from operating activities 312.39 M312.19 M236.84 M — Cash from investing activities 63.54 M46.34 M18.87 M — Cash from financing activities 424.91 M301.32 M297.31 M — Free cash flow 312.39 M312.19 M236.84 M —

Nouvelles

Alvotech: Why FDA Delays Don't Break The Bull Case (NASDAQ:ALVO)

Teva Pharmaceuticals: Why It’s Time To Cash Out (Downgrade) (NYSE:TEVA)

Alvotech: Initiating With Hold Rating On FDA CRL AVT05 And Reduced EBITDA Guidance (ALVO)

Johnson & Johnson Q3 Earnings Surprise, Icotrokinra Shines Again (NYSE:JNJ)

My Top 5 Biotech Stocks Big Pharma Could Buy Next

Alvotech (ALVO) Presents at Morgan Stanley 23rd Annual Global

Alvotech 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:ALVO)

Alvotech (ALVO) Q2 2025 Earnings Call Transcript

Johnson & Johnson Stock Just Proved The Bears Wrong Again (NYSE:JNJ)

Alvotech (ALVO) Q4 2024 Earnings Call Transcript

Why Organon Is A Top Pick For Income Investors (NYSE:OGN)